Peer-reviewed veterinary case report
Arctic fox treated with mercury oxide for tail infection got liver
By Yang, BaoLian et al.·Published in Frontiers in veterinary science·2025·College of Veterinary Medicine, China·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Case Report: Successful management of hepatic injury secondary to mercury (II) oxide poisoning in awith tail gland infection.
- Species:
- wildlife
Plain-English summary
A female Arctic fox was brought in with a tail gland infection that didn't improve after initial treatment and surgery. After worsening symptoms like loss of appetite, dark urine, and weight loss, further tests revealed severe mercury poisoning from a topical medication. The vet removed the medication and provided a combination of treatments, including intravenous medications for liver protection and infection, as well as oral chelating agents to remove the mercury. After four weeks of treatment, the fox's health improved significantly, and her blood tests returned to normal, indicating a good recovery.
People also search for: Arctic fox tail gland infection treatment · mercury poisoning in wildlife · how to treat fox liver injury
Abstract
A 6.08 kg female stray Arctic fox () of unknown age was presented with tail gland inflammation. Initial conventional therapy and subsequent tail amputation at a primary veterinary facility resulted in limited improvement. Subsequently, a topical medication red mercuric oxide () was applied for 4 weeks. Although the local infection showed signs of improvement, the fox subsequently developed progressive systemic signs, including anorexia, dark urine, and weight loss, prompting referral. Clinical examination revealed a large amount of cherry-red medication covering the wound. Hematological tests indicated elevated neutrophils and C-reactive protein (CRP), suggesting an inflammatory response. Serum biochemistry revealed elevated levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and total bile acids (TBA), indicating hepatobiliary injury, alongside an elevated creatine kinase (CK) suggestive of abnormal muscle metabolism. The whole-blood mercury concentration was significantly elevated (4.7583 μg/L). Imaging findings included: ultrasound showing gallbladder sludge, abnormal liver parenchyma echogenicity, and indistinct kidney contours; X-ray revealed gastric gas, liver edge extending beyond the costal arch, blurred renal contours, and significantly increased density in the tail gland area. The Arctic fox was diagnosed with chronic topical mercury (II) oxide-induced mercury poisoning and secondary liver injury. The treatment regimen included: (1) removal of the topical medication and surgical debridement; (2) intravenous administration of reduced glutathione (hepatoprotection), ceftiofur sodium (anti-infective), and vitamin C (antioxidant); (3) oral administration of a mercury chelating agent (dimercaptosuccinic acid) and choleretics (ursodeoxycholic acid); and (4) intramuscular injection of appetite stimulants. After 4 weeks of systemic treatment, the fox's abnormal biochemical parameters returned to normal, and the prognosis was good. This case addresses a specific gap in the diagnosis and treatment of heavy metal poisoning in wildlife. It provides a valuable reference for the clinical management of poisoning cases associated with topical mercury-containing wound medications.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41647434/